See more : New Concepts Holdings Limited (2221.HK) Income Statement Analysis – Financial Results
Complete financial analysis of Aesthetic Medical International Holdings Group Limited (AIH) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Aesthetic Medical International Holdings Group Limited, a leading company in the Medical – Care Facilities industry within the Healthcare sector.
You may be interested
- G3 VRM Acquisition Corp. (GGGVR) Income Statement Analysis – Financial Results
- Nelcast Limited (NELCAST.NS) Income Statement Analysis – Financial Results
- Holcim Ltd (HCMLF) Income Statement Analysis – Financial Results
- Megola, Inc. (MGON) Income Statement Analysis – Financial Results
- Vivid Global Industries Limited (VIVIDIND.BO) Income Statement Analysis – Financial Results
Aesthetic Medical International Holdings Group Limited (AIH)
About Aesthetic Medical International Holdings Group Limited
Aesthetic Medical International Holdings Group Limited provides aesthetic medical services. It offers surgical aesthetic treatments, such as eye surgery, rhinoplasty, breast augmentation, and liposuction; and non-surgical aesthetic treatments comprising minimally invasive and energy-based treatments, including laser, ultrasound, and ultraviolet light treatments. The company also provides general healthcare and other aesthetic medical services, such as internal medicine, urology, gynecology, and obstetrics treatment services, as well as dentistry, dermatology, and hair loss treatment services. It operates 15 treatment centers in China, Hong Kong, and Singapore. Aesthetic Medical International Holdings Group Limited was founded in 1997 and is headquartered in Shenzhen, the People's Republic of China.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 682.59M | 670.09M | 645.59M | 901.57M | 869.05M | 761.31M | 697.40M | 584.86M |
| Cost of Revenue | 360.54M | 314.51M | 376.09M | 356.80M | 275.95M | 258.57M | 234.52M | 217.34M |
| Gross Profit | 322.05M | 355.59M | 269.50M | 544.78M | 593.10M | 502.74M | 462.87M | 367.52M |
| Gross Profit Ratio | 47.18% | 53.07% | 41.74% | 60.43% | 68.25% | 66.04% | 66.37% | 62.84% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 138.61M | 150.38M | 206.97M | 230.65M | 196.33M | 115.49M | 92.84M | 121.76M |
| Selling & Marketing | 232.25M | 226.47M | 404.68M | 510.61M | 413.07M | 333.53M | 300.36M | 231.23M |
| SG&A | 370.86M | 376.85M | 611.65M | 741.25M | 609.40M | 449.01M | 393.20M | 352.99M |
| Other Expenses | 8.30M | -51.43M | 1.83M | -999.00K | 195.41M | -280.21M | -115.72M | 50.73M |
| Operating Expenses | 370.86M | 376.85M | 611.65M | 741.25M | 609.40M | 449.01M | 393.20M | 352.99M |
| Cost & Expenses | 731.40M | 691.36M | 987.75M | 1.10B | 885.35M | 707.58M | 627.72M | 570.33M |
| Interest Income | 78.00K | 155.00K | 113.00K | 1.19M | 388.00K | 322.00K | 868.00K | 309.00K |
| Interest Expense | 14.47M | 21.64M | 27.23M | 29.19M | 23.91M | 9.24M | 6.58M | 2.92M |
| Depreciation & Amortization | 65.90M | 61.49M | 99.14M | 106.41M | 83.83M | 32.14M | 29.11M | 38.73M |
| EBITDA | 25.47M | 9.67M | -240.99M | -90.93M | 177.37M | -192.29M | -17.48M | 91.91M |
| EBITDA Ratio | 3.73% | -1.65% | -37.33% | -21.89% | 20.41% | -25.26% | -2.51% | 18.11% |
| Operating Income | -48.81M | -72.54M | -340.13M | -303.74M | 93.54M | -227.49M | -50.83M | 66.98M |
| Operating Income Ratio | -7.15% | -10.83% | -52.68% | -33.69% | 10.76% | -29.88% | -7.29% | 11.45% |
| Total Other Income/Expenses | -6.25M | -72.91M | -339.16M | -63.02M | 168.66M | -287.70M | -122.85M | 10.51M |
| Income Before Tax | -55.06M | -94.17M | -681.31M | -259.49M | 152.36M | -233.97M | -53.17M | 64.24M |
| Income Before Tax Ratio | -8.07% | -14.05% | -105.53% | -28.78% | 17.53% | -30.73% | -7.62% | 10.98% |
| Income Tax Expense | -15.14M | -18.07M | -11.80M | -12.59M | 14.04M | 18.51M | 19.26M | 13.71M |
| Net Income | -37.43M | -76.11M | -669.52M | -246.91M | 136.31M | -255.24M | -76.68M | 50.35M |
| Net Income Ratio | -5.48% | -11.36% | -103.71% | -27.39% | 15.68% | -33.53% | -10.99% | 8.61% |
| EPS | -0.85 | -2.79 | -30.45 | -11.36 | 5.77 | -4.45 | -1.34 | 0.89 |
| EPS Diluted | -0.85 | -2.79 | -30.45 | -11.36 | 5.77 | -4.45 | -1.34 | 0.89 |
| Weighted Avg Shares Out | 43.89M | 27.30M | 21.99M | 21.74M | 23.61M | 57.40M | 57.40M | 56.66M |
| Weighted Avg Shares Out (Dil) | 43.89M | 27.30M | 21.99M | 21.74M | 23.61M | 57.40M | 57.40M | 56.66M |
Aesthetic Medical International Reports First Half of 2023 Unaudited Financial Results
SHENZHEN, China, Sept. 05, 2023 (GLOBE NEWSWIRE) -- Aesthetic Medical International Holdings Group Limited (Nasdaq: AIH) (the “Company” or “AIH”), a leading provider of aesthetic medical services in China, announced its unaudited financial results for the six months ended June 30,...
Aesthetic Medical International Announces (i) Closing of Share Transfer, Issue of Conversion Shares, and Issue of Warrants, (ii) Resignations and Appointment of Directors, (iii) Release of Share Pledge, and (iv) Entry into certain Contractual Arrangements with respect to Equity Interests
Closing of Share Transfer, Issue of Conversion Shares, and Issue of Warrants Reference is made to the press release of the Company filed with the Securities and Exchange Commission (the “SEC”) on July 20, 2022 and form 6-K of the...
Aesthetic Medical International to Announce First Quarter 2023 Unaudited Financial Results on May 17, 2023
SHENZHEN, China, May 11, 2023 (GLOBE NEWSWIRE) -- Aesthetic Medical International Holdings Group Limited (Nasdaq: AIH) (the “Company” or “AIH”), a leading provider of aesthetic medical services in China, today announced that it will release its unaudited financial results for...
Aesthetic Medical International to Announce FY2022 Annual Report on April 21, 2023
SHENZHEN, China, April 14, 2023 (GLOBE NEWSWIRE) -- Aesthetic Medical International Holdings Group Limited (Nasdaq: AIH) (the “Company” or “AIH”), a leading provider of aesthetic medical services in China, today announced that it will release its annual report for the...
Aesthetic Medical International Holdings Group Limited (AIH) Q3 2022 Earnings Call Transcript
Aesthetic Medical International Holdings Group Limited (NASDAQ:AIH ) Q3 2022 Results Conference Call November 29, 2022 7:00 AM ET Company Participants Derrick Shi - IR Associate Director Pengwu Zhou - Chairman, CEO Toby Wu - CFO Operator Good morning, ladies...
Aesthetic Medical International to Announce Third Quarter 2022 Unaudited Financial Results on November 29, 2022
SHENZHEN, China, Nov. 22, 2022 (GLOBE NEWSWIRE) -- Aesthetic Medical International Holdings Group Limited (Nasdaq: AIH) (the “Company” or “AIH”), a leading provider of aesthetic medical services in China, today announced that it will release its unaudited financial results for...
Aesthetic Medical International Holdings Group Limited (AIH) CEO Pengwu Zhou on Q2 2022 Results - Earnings Call Transcript
Aesthetic Medical International Holdings Group Limited (NASDAQ:AIH ) Q2 2022 Earnings Conference Call August 17, 2022 8:00 AM ET Company Participants Pengwu Zhou - Chairman & Chief Executive Officer Derrick Chi - Investor Relations Associate Director Toby Wu - Chief...
Aesthetic Medical International to Announce Unaudited Financial Results for the First Half of 2022 on August 17, 2022
SHENZHEN, China, Aug. 10, 2022 (GLOBE NEWSWIRE) -- Aesthetic Medical International Holdings Group Limited (Nasdaq: AIH) (the “Company” or “AIH”), a leading provider of aesthetic medical services in China, today announced that it will release its unaudited financial results for...
Aesthetic Medical International Holdings Group Limited (AIH) CEO Dr. Pengwu Zhou on Q2 2021 Results - Earnings Call Transcript
Aesthetic Medical International Holdings Group Limited (AIH) CEO Dr. Pengwu Zhou on Q2 2021 Results - Earnings Call Transcript
Aesthetic Medical International to Announce Unaudited Financial Results for the Second Quarter and First Half of 2021 on November 16, 2021
SHENZHEN, China, Nov. 08, 2021 (GLOBE NEWSWIRE) -- Aesthetic Medical International Holdings Group Limited (Nasdaq: AIH) (the “Company” or “AIH”), a leading provider of aesthetic medical services in China, today announced that it will release its unaudited financial results for...
Source: https://incomestatements.info
Category: Stock Reports